Aperio Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.4M Buy
36,852
+1,346
+4% +$77.4K 0.01% 1151
2020
Q3
$1.76M Sell
35,506
-3,494
-9% -$180K 0.01% 1175
2020
Q2
$1.86M Buy
39,000
+674
+2% +$32.5K 0.01% 1145
2020
Q1
$1.63M Sell
38,326
-6,458
-14% -$319K 0.01% 1101
2019
Q4
$2.64M Buy
44,784
+2,324
+5% +$126K 0.01% 969
2019
Q3
$2.17M Sell
42,460
-2,274
-5% -$108K 0.01% 1017
2019
Q2
$1.89M Sell
44,734
-2,448
-5% -$106K 0.01% 1081
2019
Q1
$2.33M Sell
47,182
-8,138
-15% -$368K 0.01% 975
2018
Q4
$2.39M Sell
55,320
-17,969
-25% -$897K 0.01% 907
2018
Q3
$4.16M Buy
73,289
+62
+0.1% +$3.26K 0.02% 749
2018
Q2
$3.69M Buy
73,227
+3,508
+5% +$183K 0.02% 773
2018
Q1
$3.47M Buy
69,719
+26,931
+63% +$1.27M 0.02% 779
2017
Q4
$1.76M Buy
42,788
+4,356
+11% +$152K 0.01% 1034
2017
Q3
$1.14M Buy
38,432
+4,297
+13% +$131K 0.01% 1196
2017
Q2
$1.13M Buy
34,135
+19,437
+132% +$610K 0.01% 1173
2017
Q1
$435K Buy
14,698
+6,296
+75% +$172K ﹤0.01% 1626
2016
Q4
$208K Buy
+8,402
New +$191K ﹤0.01% 1990

Other funds holding GMED

Aperio Group's GMED Position: Q4 2020 in Review

Aperio Group increased its Globus Medical (GMED) stake by 3.8% in Q4 2020, buying an estimated $77.4K and bringing the position to 36,852 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #1151.

Aperio Group first reported a position in GMED in Q4 2016 and has held it in 17 quarters since. The position peaked at $4.16M in Q3 2018. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Aperio Group held 36,852 shares of Globus Medical worth $2.4M as of Q4 2020.
  • Aperio Group bought 1,346 Globus Medical shares in Q4 2020, an estimated $77.4K.
  • Globus Medical made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1151 holding.
  • Aperio Group first reported a position in Globus Medical in Q4 2016 and has held it in 17 quarters since.
  • Aperio Group's Globus Medical position peaked at $4.16M in Q3 2018.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.